Rockwell Medical, Inc. to Sponsor Triferic® Exhibitor Spotlight Presentation at American Society of Nephrology Conference

    NEXT STORY
    FibroGen Presents Phase 3 Efficacy and Safety Results for Roxadustat Versus Epoetin Alfa as Treatment of Anemia in Incident Dialysis Patients with Chronic Kidney Disease
    PREV STORY
    Molecular Templates Hosting Analyst & Investor Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature

    author_avatar
    NASDAQ Market News

    Tyme Technologies Provides Clinical and Corporate Update for Fiscal 1Q 2019

    NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Prefilled Syringes Market to Reach USD 10.57 Billion by 2026; Introduction of BD’s Disposable Autoinjector to Aid Expansion, states Fortune Business Insights™

    author_avatar
    NASDAQ Market News